Priyam Shah | IR |
Brian McKelligon | CEO |
John Ek | CFO |
Kyle Mikson | Canaccord Genuity |
Lucas Baranowski | UBS |
Rachel Vatnsdal | JPMorgan Chase |
Mark Massaro | BTIG |
Edmund Tu | Morgan Stanley |
Tim Chiang | Capital One |
David Westenberg | Piper Sandler |
Mason Carrico | Stephens Inc. |
Good day and welcome to the Akoya Biosciences Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session.
As a reminder, this call is being recorded.
I would now like to turn the call over to Priyam Shah, Head of Investor Relations at Akoya Biosciences.